Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rendell

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Acta Diabetologica Latina|April 1, 1983
The expanding clinical use of C-peptide radioimmunoassayM Rendell
Muscle & Nerve|March 1, 1996
Quantitative measurement of cutaneous perception in diabetic neuropathyM Rendell
Drugs of Today (Barcelona, Spain : 1998)|January 15, 2015
Technosphere inhaled insulin (Afrezza)M Rendell
Drugs of Today (Barcelona, Spain : 1998)|April 17, 2015
First fixed-ratio combination of insulin degludec and liraglutide for the treatment of type 2 diabetesM Rendell
The New England Journal of Medicine|May 11, 2000
Dietary treatment of diabetes mellitusM Rendell
The Journal of Clinical Endocrinology and Metabolism|December 1, 1983
C-peptide levels as a criterion in treatment of maturity-onset diabetesM Rendell
Drugs of Today (Barcelona, Spain : 1998)|June 29, 2013
Insulin degludec: a long-acting modern insulin analogue with a predictable pharmacokinetic/pharmacodynamic profileM Rendell
The American Journal of Medicine|December 1, 1992
Diabetic cutaneous microangiopathyM Rendell, O Bamisedun
Angiology|October 1, 1992
Skin blood flow and current perception in pentoxifylline-treated diabetic neuropathyM Rendell, O Bamisedun
Clinical Endocrinology|June 1, 1985
'Chemical hyperthyroidism': the significance of elevated serum thyroxine levels in L-thyroxine treated individualsM Rendell, D Salmon
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Acta Diabetologica Latina|April 1, 1983
The expanding clinical use of C-peptide radioimmunoassayM Rendell
Muscle & Nerve|March 1, 1996
Quantitative measurement of cutaneous perception in diabetic neuropathyM Rendell
Drugs of Today (Barcelona, Spain : 1998)|January 15, 2015
Technosphere inhaled insulin (Afrezza)M Rendell
Drugs of Today (Barcelona, Spain : 1998)|April 17, 2015
First fixed-ratio combination of insulin degludec and liraglutide for the treatment of type 2 diabetesM Rendell
The New England Journal of Medicine|May 11, 2000
Dietary treatment of diabetes mellitusM Rendell
The Journal of Clinical Endocrinology and Metabolism|December 1, 1983
C-peptide levels as a criterion in treatment of maturity-onset diabetesM Rendell
Drugs of Today (Barcelona, Spain : 1998)|June 29, 2013
Insulin degludec: a long-acting modern insulin analogue with a predictable pharmacokinetic/pharmacodynamic profileM Rendell
The American Journal of Medicine|December 1, 1992
Diabetic cutaneous microangiopathyM Rendell, O Bamisedun
Angiology|October 1, 1992
Skin blood flow and current perception in pentoxifylline-treated diabetic neuropathyM Rendell, O Bamisedun
Clinical Endocrinology|June 1, 1985
'Chemical hyperthyroidism': the significance of elevated serum thyroxine levels in L-thyroxine treated individualsM Rendell, D Salmon
Pageof 8